Johns Hopkins University, Bloomberg School of Public Health, Department of Environmental Health Sciences, 615 N. Wolfe St., Baltimore, MD 21205-2200, USA.
Placenta. 2012 May;33(5):424-32. doi: 10.1016/j.placenta.2012.02.009. Epub 2012 Mar 3.
Characterization of normal changes in the serum proteome during pregnancy may enhance understanding of maternal physiology and lead to the development of new gestational biomarkers. In 23 Nepalese pregnant women who delivered at term, two-dimensional difference in-gel electrophoresis (DIGE) was used to assess changes in relative protein abundance between paired serum samples collected in the first and third trimesters. One-hundred and forty-five of over 700 protein spots in DIGE gels (pI 4.2-6.8) exhibited nominally significant (p < 0.05) differences in abundance across trimesters. Additional filtering using a Bonferroni correction reduced the number of significant (p < 0.00019) spots to 61. Mass spectrometric analysis detected 38 proteins associated with gestational age, cytoskeletal remodeling, blood pressure regulation, lipid and nutrient transport, and inflammation. One new protein, pregnancy-specific β-glycoprotein 4 was detected. A follow-up isotope tagging for relative and absolute quantitation (iTRAQ) experiment of six mothers from the DIGE study revealed 111 proteins, of which 11 exhibited significant (p < 0.05) differences between trimesters. Four of these proteins: gelsolin, complement C1r subcomponent, α-1-acid glycoprotein, and α-1B-glycoprotein also changed in the DIGE analysis. Although not previously associated with normal pregnancy, gelsolin decreased in abundance by the third trimester (p < 0.01) in DIGE, iTRAQ and Western analyses. Changes in abundance of proteins in serum that are associated with syncytiotrophoblasts (gelsolin, pregnancy-specific β-1 glycoprotein 1 and β-2-glycoprotein I) probably reflect dynamics of a placental proteome shed into maternal circulation during pregnancy. Measurement of changes in the maternal serum proteome, when linked with birth outcomes, may yield biomarkers for tracking reproductive health in resource poor settings in future studies.
正常妊娠期间血清蛋白质组的特征变化可能有助于理解母体生理学,并导致新的妊娠生物标志物的发展。在 23 名尼泊尔足月分娩的孕妇中,使用二维差异凝胶电泳(DIGE)评估了在第一和第三孕期采集的配对血清样本中相对蛋白质丰度的变化。在 DIGE 凝胶(pI 4.2-6.8)中的 700 多个蛋白质斑点中的 145 个(p <0.05)表现出丰度在整个孕期有显著差异。使用 Bonferroni 校正进行额外的过滤将显著(p <0.00019)的斑点数量减少到 61 个。质谱分析检测到与妊娠年龄、细胞骨架重塑、血压调节、脂质和营养物质转运以及炎症相关的 38 种蛋白质。一种新的蛋白质,妊娠特异性β-糖蛋白 4 被检测到。对 DIGE 研究中的 6 位母亲进行的后续同位素质谱标记相对和绝对定量(iTRAQ)实验显示了 111 种蛋白质,其中 11 种在孕期之间表现出显著差异(p <0.05)。在 DIGE 分析中,其中四种蛋白质:凝胶蛋白、补体 C1r 亚成分、α-1-酸性糖蛋白和α-1B-糖蛋白也发生了变化。尽管以前与正常妊娠无关,但在 DIGE、iTRAQ 和 Western 分析中,凝胶蛋白在第三孕期的丰度降低(p <0.01)。与合胞体滋养层相关的血清蛋白丰度的变化(凝胶蛋白、妊娠特异性β-1 糖蛋白 1 和β-2-糖蛋白 I)可能反映了怀孕期间胎盘蛋白质组向母体循环中释放的动力学。与出生结局相关的母体血清蛋白质组变化的测量可能会在未来的研究中为资源匮乏地区的生殖健康追踪提供生物标志物。